Cardiac Science will become part of ZOLL’s Resuscitation division, headquartered in Chelmsford, Massachusetts

medicine-3298451_640

Image: ZOLL will continue to promote, market, and supply the Powerheart line of AEDs. Photo: Courtesy of Adam Radosavljevic from Pixabay.

ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today confirmed that it has completed the previously announced acquisition of Cardiac Science Corporation, a leading provider of automated external defibrillators (AEDs), related services, and accessories.

“We are excited about the alignment of our two companies and our combined ability to place lifesaving technology into the hands of more lay rescuers and first responders during medical emergencies,” said Elijah A. White, President of ZOLL Resuscitation. “This acquisition fits well into ZOLL’s vision of providing integrated, innovative acute and resuscitation care for all.”

“Cardiac Science and ZOLL both provide proven AED solutions to broad segments of the public safety market,” he explained. “With Cardiac Science now part of ZOLL, we’ll be able to offer our customers more choices and a stronger AED program management infrastructure to ensure that both families of AEDs are ready when needed.”

Cardiac Science will become part of ZOLL’s Resuscitation division, headquartered in Chelmsford, Massachusetts, but will continue manufacturing in the Deerfield, Wisconsin facility. ZOLL will continue to promote, market, and supply the Powerheart line of AEDs and Rescue Ready services as well as ZOLL AEDs and PlusTrac program management.

Source: Company Press Release